Lpl Financial LLC Precision Biosciences Inc Transaction History

Lpl Financial LLC

  • $218 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$0.29 - $0.45 $7,370 - $11,437
-25,417 Reduced 57.67%
18,658 $6,000
Q3 2023

Nov 13, 2023
BUY
$0.34 - $0.69 $312 - $634
920 Added 2.13%
44,075 $14,000
Q2 2023

Jul 31, 2023
BUY
$0.52 - $0.91 $7,459 - $13,053
14,345 Added 49.79%
43,155 $22,000
Q1 2023

May 10, 2023
BUY
$0.7 - $1.41 $7,625 - $15,359
10,893 Added 60.8%
28,810 $21,000
Q4 2022

Feb 07, 2023
BUY
$0.97 - $45.0 $17,379 - $806,265
17,917 New
17,917 $21,000

Others Institutions Holding DTIL

# of Institutions
7
Shares Held
2.56M
Call Options Held
0
Put Options Held
0
View Full List

About PRECISION BIOSCIENCES INC

DTIL Quotes by TradingView
  • Ticker DTIL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 110,818,000
  • Market Cap $539M
  • Description
  • Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...
More about DTIL
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email